Frontlight ResearchEarly access
Trial site
CENTRUM MEDYCZNE HOPE CLINIC
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Immunovant Sciences GmbH2 trials
- NMD Pharma A/S2 trials
- Aurinia Pharmaceuticals Inc.1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myasthenia gravis3 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026